Three steps toward dose optimization for oncology dose finding
Background: Traditional dose selection for oncology registration trials typically employs a one- or two-step single maximum tolerated dose (MTD) approach. However, this approach may not be appropriate for molecularly targeted therapy, which tends to have toxicity profiles that are markedly different...
| Published in: | Contemporary Clinical Trials Communications |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-08-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2451865424000760 |
